facebook linked in twitter
close

Lori B. Metrock

Partner

One Nashville Place
150 Fourth Avenue, North
Suite 1100
Nashville, TN 37219
lori.metrock@nelsonmullins.com

Lori Metrock practices in the areas of corporate and securities law and mergers and acquisitions. She advises public companies and handles their public and private securities offerings, corporate governance, and Exchange Act compliance work. Her private company work includes private offerings of securities, corporate governance counsel, general corporate work, and mergers and acquisitions.

She advises NASDAQ...

+ Read More

Lori Metrock practices in the areas of corporate and securities law and mergers and acquisitions. She advises public companies and handles their public and private securities offerings, corporate governance, and Exchange Act compliance work. Her private company work includes private offerings of securities, corporate governance counsel, general corporate work, and mergers and acquisitions.

She advises NASDAQ and NYSE listed companies as well as REIT clients on their regulatory compliance.

and NYSE listed companies as well as REIT clients on their regulatory compliance.

Lori Metrock practices in the areas of corporate and securities law and mergers and acquisitions. She advises public companies and handles their public and private securities offerings, corporate governance, and Exchange Act compliance work. Her private company work includes private offerings of securities, corporate governance counsel, general corporate work, and mergers and acquisitions.

She advises NASDAQ... and NYSE listed companies as well as REIT clients on their regulatory compliance.

Experience

Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.

Representative Matters

Securities and Public Company Experience

  • Represented NASDAQ-listed home health, hospice, and personal care company in a $179 million privately negotiated stock repurchase
  • Represented bank holding company in a $55 million initial public offering on the New York Stock Exchange
  • Registration Statement on Form S-4 for issuance of common stock in connection with $28.6 million merger transaction
  • Represented NYSE listed bank holding company in $40 million public offering of subordinated notes
  • Represented a biopharmaceutical drug company in connection with a $15 million follow-on offering
  • Listed warrants of biopharmaceutical company on NYSE MKT
  • Registration Statement on Form S-4 for issuance of common stock in connection with $37.5 million merger transaction
  • Represented NYSE listed financial services company in a $20 million private placement of subordinated notes
  • Served as Tennessee counsel to NYSE listed public company in connection with $500 million registered notes offering
  • Represented client, assisting with shelf registration statements on Form S-3 and subsequent takedowns, including ASRs
  • Represented a public company in $120 million offering 7.5% convertible notes pursuant to Rule 144A
  • Represented a public company in a registered exchange offering of $1.9 billion of senior notes in a section 144A transaction
  • Represented NYSE listed company in multiple resale registration on Form S-3 for selling shareholders and subsequent prospectus updates
  • Securities compliance of private funds with public companies in their portfolios
  • Represented a client in a going-private transaction, effected by a reclassification of common stock into different classes of equity

Corporate/Mergers and Acquisitions Experience

  • Represented public office and industrial REIT in connection with $600 million merger transaction on Form S-4
  • Represented self-storage REIT in connection with internalization transaction
  • Represented public company in $500 million acquisition and related financing, including $100 million of privately placed securities
  • Represented public over-the-counter healthcare company in $200 million and $90 million acquisitions of OTC drug brands
  • Represented NYSE listed national retail company, overseeing its internal corporate reorganization
  • Represented over-the-counter healthcare company, overseeing its internal corporate reorganization

Education

  • Vanderbilt Law School, JD (2007)
    • Authorities editor, Vanderbilt Journal of Transnational Law
  • Vanderbilt University, BA, summa cum laude, Phi Beta Kappa (2003)

Admissions

  • Tennessee

Practice Areas

Industries

The bar rules of some states require that the standards for an attorney's inclusion in certain public accolades or recognitions be provided. When such accolades or recognitions are listed, a hyperlink is provided that leads to a description of the respective selection methodology.

What's New
Idea Exchange
Top